Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
11551
PUT
Apollo Commercial Real Estate
ARI
$876M
| $139K | ﹤0.01% |
13,700
-46,700
| -77% | -$476K |
|
11552
PUT
CytomX Therapeutics
CTMX
$732M
| $139K | ﹤0.01% |
43,500
-62,500
| -59% | -$141K |
|
|
ABX
11553
PUT
Abacus Global Management
ABX
$907M
| $139K | ﹤0.01% |
24,200
-28,700
| -54% | -$170K |
|
11554
PUT
Avalo Therapeutics
AVTX
$1.05B
| $139K | ﹤0.01% |
+10,900
| New | +$93.7K |
|
11555
InflaRx
IFRX
$301M
| $138K | ﹤0.01% |
+102,951
| New | +$109K |
|
11556
PUT
Zura Bio
ZURA
$534M
| $138K | ﹤0.01% |
+31,800
| New | +$57.2K |
|
11557
Jerash Holdings
JRSH
$67.3M
| $138K | ﹤0.01% |
41,450
+10,912
| +36% | +$36.7K |
|
11558
PUT
AerSale
ASLE
$280M
| $138K | ﹤0.01% |
16,800
-6,000
| -26% | -$45.2K |
|
11559
Virgin Galactic
SPCE
$503M
| $137K | ﹤0.01% |
35,542
-74,444
| -68% | -$250K |
|
|
AIRJ
11560
Montana Technologies Corp
AIRJ
$437M
| $137K | ﹤0.01% |
+29,217
| New | +$137K |
|
|
BIOA
11561
PUT
BioAge Labs
BIOA
$487M
| $137K | ﹤0.01% |
23,300
-1,000
| -4% | -$4.68K |
|
11562
Identive
INVE
$64.2M
| $137K | ﹤0.01% |
+39,704
| New | +$142K |
|
11563
CALL
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.4M
| $137K | ﹤0.01% |
2,110
+250
| +13% | +$19.4K |
|
11564
PUT
GrowGeneration
GRWG
$104M
| $137K | ﹤0.01% |
73,200
+51,300
| +234% | +$70.3K |
|
11565
PUT
Ocugen
OCGN
$458M
| $137K | ﹤0.01% |
83,800
-12,500
| -13% | -$13.8K |
|
|
CAN
11566
CALL
Canaan Creative
CAN
$171M
| $136K | ﹤0.01% |
154,800
-60,600
| -28% | -$46K |
|
|
VIVO
11567
PUT
VivoPower PLC
VIVO
$150M
| $136K | ﹤0.01% |
+30,300
| New | +$156K |
|
|
NFGC
11568
CALL
New Found Gold
NFGC
$649M
| $136K | ﹤0.01% |
57,500
+30,100
| +110% | +$53K |
|
|
VTYX
11569
CALL
DELISTED
Ventyx Biosciences
VTYX
| $136K | ﹤0.01% |
43,800
+800
| +2% | +$2.12K |
|
11570
PUT
Myriad Genetics
MYGN
$290M
| $136K | ﹤0.01% |
18,800
+4,600
| +32% | +$27.3K |
|
|
OYSEU
11571
Oyster Enterprises II Acquisition Corp Units
OYSEU
| $135K | ﹤0.01% |
+13,219
| New | +$134K |
|
|
AGNT
11572
CALL
AGNT Inc
AGNT
$727M
| $135K | ﹤0.01% |
12,700
-15,300
| -55% | -$162K |
|
|
PHLT
11573
CALL
DELISTED
Performant Healthcare Inc
PHLT
| $135K | ﹤0.01% |
17,500
+6,200
| +55% | +$39.5K |
|
|
LAR
11574
PUT
Lithium Argentina AG
LAR
$1.12B
| $135K | ﹤0.01% |
40,500
-8,100
| -17% | -$24.5K |
|
11575
CALL
Wabash National
WNC
$512M
| $135K | ﹤0.01% |
13,700
-15,900
| -54% | -$170K |
|
Similar funds
Ken Griffin's Q3 2025 Portfolio in Review
As of Q3 2025, Ken Griffin held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin's Q3 2025 filing shows 2,292 new, 5,364 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Ken Griffin's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Ken Griffin fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Ken Griffin's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Ken Griffin opened 2,292 new positions and closed 1,963 in Q3 2025.
- Ken Griffin's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.